Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILE: Hydroxychloroquine in Incomplete Lupus Erythematosus
NCT03030118Phase 2Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Dec 2017
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in lupus erythematosus (SLE), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Dec 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03030118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03030118.